Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Arcutis Biotherapeutics, Inc. (ARQT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Edwards Larry Todd (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 60,000 shares @ $0
Granted 240,000 options to buy @ $5.58, valued at $1.3M
10/03/2023 3 Edwards Larry Todd (Chief Commercial Officer) has filed a Form 3 on Arcutis Biotherapeutics, Inc.
09/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employee Invention Assignment and Confidentiality Agreement by and",
"FOR IMMEDIATE RELEASE Arcutis Appoints L. Todd Edwards"
08/22/2023 4 Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 300 shares @ $7.05, valued at $2.1k
Sold 1,305 shares @ $7.04, valued at $9.2k
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 8-K Quarterly results
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update"
06/02/2023 4 Matsuda Masaru (See Remark) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,875 shares @ $0
Sold 1,830 shares @ $7.8023, valued at $14.3k
Granted 1,463 shares @ $6.38, valued at $9.3k
06/02/2023 4 LIN SUE-JEAN (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Heron Patrick J (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 CHAUDHURI BHASKAR (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Curran Terrie (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Leonard Keith R (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Krishnamohan Neha (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
06/02/2023 4 Welgus Howard G. (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 4,375 shares @ $0
Granted 12,220 options to buy @ $7.51, valued at $91.8k
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Arcutis Announces Leadership Transition"
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Arcutis Announces First Quarter 2023 Financial Results and Provides Business Update"
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/18/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
03/31/2023 4/A Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Granted 87,500 shares @ $0
Granted 232,000 options to buy @ $15.82, valued at $3.7M
03/08/2023 4 Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 2,435 shares @ $15.2638, valued at $37.2k
03/08/2023 4 Burrows Scott L (CFO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 291 shares @ $15.2634, valued at $4.4k
03/08/2023 4 Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 851 shares @ $15.2634, valued at $13k
03/08/2023 4 Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 831 shares @ $15.2635, valued at $12.7k
03/08/2023 4 OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 690 shares @ $15.2634, valued at $10.5k
03/08/2023 4 Lock Kenneth A. (Chief Commercial Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 831 shares @ $15.2636, valued at $12.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy